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For the past little while I have seen a variety of headlines in the 
various news and medical websites I look at daily. ‘BAT not out of 
puff just yet’[1] came up on businesslive.co.za recently, reporting 
on British American Tobacco (BAT)’s purchase of e-cigarette seller 
Twisp in the light of falling cigarette sales. Trawling the internet 
has suggested to me that views on the efficacy of vaping as a way of 
helping people stop (or never start) smoking are equivocal – probably 
not surprising, given the paucity of evidence in either direction. But 
during the past month, different headlines have been appearing. 
‘US health officials warn against vaping’[2] followed on from reports 
of more than 450  cases of severe pulmonary disease in the USA,[3] 
across 33 states and including several deaths. Primary clinical features 
include respiratory symptoms such as cough, shortness of breath or 
chest pain, with some cases including gastrointestinal symptoms such 
as nausea, diarrhoea and vomiting. All the patients reported using 
e-cigarettes before symptoms started. These illnesses have caused 
health officials in the USA to warn people against using e-cigarettes 
while the cases are investigated.
I must admit to disliking vaping as much as I do cigarette smok-
ing, and would not allow someone to vape in my home. But that 
prejudice aside, how is it that something as widely used by such an 
enormous range of people has simply been allowed onto the market 
with no thought of the potential for adverse effects? We know the 
dangers of nicotine (and the concomitant dangers of conventional 
cigarettes as a vehicle for the highly addictive substance), but we 
know little or nothing about the effects of the potentially toxic 
substances found in e-cigarettes. Vapers are essentially the guinea 
pigs for what has been described as one of the biggest experiments 
in human medical history.[4] Those last words are from an article by 
Marika Sboros, published a couple of months before the reports of 
illness and death came from the USA.
In South Africa, the local e-cigarette market generated more 
than ZAR1.6 billion in sales in 2017, and at the time that this figure 
was published, projections were that it would triple over the next 
10 years. Small wonder that BAT bought Twisp. But even before the 
reports in the USA, people were wary of the potential for adverse 
effects from vaping. The Heart and Stroke Foundation South 
Africa came out strongly against vaping, and the South African 
Thoracic Society is far from happy about it. As several people have 
pointed out, we need a few decades of data before we can draw any 
conclusions about whether or not vaping is safe. Scientists in the 
USA think that the cause of the illnesses seen may be contaminants 
or faulty devices, particularly as no cases have been seen elsewhere 
in the world and no single substance or e-cigarette product has been 
consistently associated with illness.[5] However, it is possible that the 
flavourants used in vaping products may be to blame. The lack of 
data makes it impossible to make a conclusion one way or another – 
we cannot say e-cigarettes are safer, but equally we cannot say that 
they are harmful. We do, however, know that smoking conventional 
cigarettes is harmful, and vaping may 
well be the lesser of two evils. Let’s just 
hope it doesn’t take as long as it did with 
tobacco to find out the harms. With this 
in mind, beware of the industry’s efforts 
to obfuscate – which should be a lesson we 
have learnt by now.
Bridget Farham
Editor
ugqirha@iafrica.com
1. Njobeni S. BAT not out of puff just yet. Financialmail, 12 September 2019. https://www.businesslive.
co.za/fm/money-and-investing/2019-09-12-bat-not-out-of-puff-just-yet/ (accessed 14 October 2019).
2. Rocco M. US health officials warn against vaping. BusinessLIVE, 16 September 2019. https://www.
businesslive.co.za/ft/life/2019-09-16-us-health-officials-warn-against-vaping/ (accessed 14 October 2019).
3. Hammond D. Outbreak of pulmonary disease linked to vaping. BMJ  2019;366:15445. https://doi.
org/10.1136/bmj.l5445
4. Sboros M. Is vaping a potential killer or a useful aid? BusinessDay, 28 July 2019. https://www.
businesslive.co.za/bd/life/2019-07-29-marika-sboros-is-vaping-a-potential-killer-or-a-useful-aid/ 
(accessed 14 October 2019).
5. Centers for Disease Control and Prevention. Investigation notice: Outbreak of lung illness associated 
with using e-cigarette products. September 2019.  www.cdc.gov/tobacco/basic_information/e-
cigarettes/severe-lung-disease.html (accessed 14 October 2019).
S Afr Med J 2019;109(11):816. https://doi.org/10.7196/SAMJ.2019.v109i11.14440
Vaping – not the smoke-ending panacea
816       November 2019, Vol. 109, No. 11
